Hydrogenology
Hydrogenology editorial study record

Hydrogen-rich saline alleviates kidney fibrosis following acute kidney injury and retains Klotho expression

Chen J et al. · Front Pharmacol. 2017;8:499.

PreclinicalOther formsPublished 2017
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled mouse bilateral-renal-ischemia experiment with 14- and 28-day treatment endpoints

Research topic

Kidney and urinary health

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Male C57 mice with 35-minute bilateral renal-pedicle occlusion

Sample

30 mice across sham, ischemia-reperfusion and ischemia-reperfusion plus H₂-saline groups, n=10 per group

Duration

14 or 28 days

Intervention

0.6 mmol/L hydrogen-rich saline, 1 mL/kg intraperitoneally every day

Hydrogen form

H₂ dissolved in saline — H₂ only, not Brown’s gas and not inhalation.

H₂ specification

0.6 mmol/L dissolved H₂.

H₂ flow

Not applicable — intraperitoneal saline, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

Ischemia-reperfusion mice receiving ordinary saline and sham-operated saline controls

Reported, not endorsed

Outcomes and reported result

Outcomes measured

BUN, creatinine, renal histology and fibrosis, α-SMA, collagen I, Klotho expression and autophagy-associated proteins

Reported result

The article reports less fibrosis, lower BUN and creatinine, higher retained Klotho expression and higher LC3-II and Beclin-1 measures with H₂ saline.

Results-extraction completeness

Dose, allocation, methods, principal results, funding and conflicts checked in the open-access full text.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Small mouse study. The authors note that steady-state autophagy markers do not prove dynamic autophagic flux and that the mechanistic relationships remain descriptive.

Applies directly to

Renal ischemia-reperfusion and subsequent fibrosis in mice, not clinical acute kidney injury.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 28848432 · DOI: 10.3389/fphar.2017.00499

Publisher access

Open-access full text is available through PMC and Frontiers.

Extraction basis

Open-access PMC/Frontiers full text and PubMed record.

Record revision

2026-08-10